Stockreport

Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights [Yahoo! Finance]

Pyxis Oncology, Inc.  (PYXS) 
PDF Pyxis Oncology retains rights to three other antibodies in development by Apexigen's licensees discovered through the APXiMAB platform BOSTON, March 27, 2024 (GLOBE N [Read more]